首页 > 最新文献

Acta Otorhinolaryngologica Italica最新文献

英文 中文
Nasopharyngeal carcinoma. A "different" head and neck tumour. Part B: treatment, prognostic factors, and outcomes. 鼻咽癌。一种“不同的”头颈部肿瘤。B部分:治疗、预后因素和结果。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-06-01 DOI: 10.14639/0392-100X-N2223
Giulio Cantù
SUMMARY Nasopharyngeal carcinoma (NPC) is the most interesting and intriguing malignant tumour located in the nasopharynx, because it is a “peculiar” malignancy, “different” from almost all the other head and neck tumours according to several points of view. Given that radiotherapy (RT) is the treatment of choice for NPC, chemotherapy (CT) has been added to standard RT to improve outcome in high-risk patients, either as an adjuvant, neoadjuvant or concurrent treatment modality with radiation. Surgery plays an important role in rescuing recurrent or persistent disease after primary (CT)RT. This second part of the review provides a critical analysis of various treatment described in the literature, both for primary cancer and for regional and distant metastases. The prognostic factors and the final results of the various treatments will also be analysed.
{"title":"Nasopharyngeal carcinoma. A \"different\" head and neck tumour. Part B: treatment, prognostic factors, and outcomes.","authors":"Giulio Cantù","doi":"10.14639/0392-100X-N2223","DOIUrl":"https://doi.org/10.14639/0392-100X-N2223","url":null,"abstract":"SUMMARY Nasopharyngeal carcinoma (NPC) is the most interesting and intriguing malignant tumour located in the nasopharynx, because it is a “peculiar” malignancy, “different” from almost all the other head and neck tumours according to several points of view. Given that radiotherapy (RT) is the treatment of choice for NPC, chemotherapy (CT) has been added to standard RT to improve outcome in high-risk patients, either as an adjuvant, neoadjuvant or concurrent treatment modality with radiation. Surgery plays an important role in rescuing recurrent or persistent disease after primary (CT)RT. This second part of the review provides a critical analysis of various treatment described in the literature, both for primary cancer and for regional and distant metastases. The prognostic factors and the final results of the various treatments will also be analysed.","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 3","pages":"155-169"},"PeriodicalIF":2.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/ef/aoi-2023-03-155.PMC10198365.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9915803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The prognostic-nutritional index in HPV-negative head and neck squamous cell carcinoma treated with upfront surgery: a multi-institutional series. 前期手术治疗hpv阴性头颈部鳞状细胞癌的预后-营养指数:一个多机构系列。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-06-01 DOI: 10.14639/0392-100X-N2358
Michele Tomasoni, Cesare Piazza, Alberto Deganello, Paolo Bossi, Giancarlo Tirelli, Piero Nicolai, Maria Cristina Da Mosto, Gabriele Molteni, Vittorio Giacomarra, Pietro Canzi, Stefano Pelucchi, Jerry Polesel, Daniele Borsetto, Paolo Boscolo-Rizzo

Objectives: To evaluate the prognostic value of pre-treatment prognostic-nutritional index (PNI) in patients with HPV-negative head and neck squamous cell carcinoma (HNSCC).

Methods: A multi-institutional retrospective series of HPV-negative, Stages II-IVB, HNSCCs treated with upfront surgery was evaluated. Correlation of pre-operative blood markers and PNI with 5-year overall (OS) and relapse-free (RFS) survival was tested using linear and restricted cubic spline models, as appropriate. The independent prognostic effect of patient-related features was assessed with multivariable models.

Results: The analysis was conducted on 542 patients. PNI ≥ 49.6 (HR = 0.52; 95% CI, 0.37-0.74) and Neutrophil-to-Lymphocyte Ratio (NLR) > 4.2 (HR = 1.58; 95% CI, 1.06-2.35) confirmed to be independent prognosticators of OS, whereas only PNI ≥ 49.6 (HR = 0.44; 95% CI, 0.29-0.66) was independently associated with RFS. Among pre-operative blood parameters, only higher values of albuninaemia and lymphocyte count (> 1.08 x 103/microL), and undetectable basophile count (= 0 103/microL) were independently associated with better OS and RFS.

Conclusions: PNI represents a reliable prognostic tool providing an independent measure of pre-operative immuno-metabolic performance. Its validity is supported by the independent prognostic role of albuminaemia and lymphocyte count, from which it is derived.

目的:评价术前预后营养指数(PNI)对hpv阴性头颈部鳞状细胞癌(HNSCC)患者的预后价值。方法:对经前期手术治疗的hpv阴性II-IVB期HNSCCs进行多机构回顾性研究。术前血液标志物和PNI与5年总生存率(OS)和无复发生存率(RFS)的相关性采用线性和限制性三次样条模型进行测试。采用多变量模型评估患者相关特征的独立预后影响。结果:对542例患者进行了分析。Pni≥49.6 (hr = 0.52;95% CI, 0.37-0.74),中性粒细胞与淋巴细胞比值(NLR) > 4.2 (HR = 1.58;95% CI, 1.06-2.35)被证实是OS的独立预后因素,而只有PNI≥49.6 (HR = 0.44;95% CI, 0.29-0.66)与RFS独立相关。在术前血液参数中,只有较高的白蛋白血症和淋巴细胞计数(> 1.08 × 103/微l)和检测不到的嗜碱性细胞计数(= 0.103 /微l)与较好的OS和RFS独立相关。结论:PNI是一种可靠的预后工具,可独立衡量术前免疫代谢表现。它的有效性得到了白蛋白血症和淋巴细胞计数的独立预后作用的支持,这是它的来源。
{"title":"The prognostic-nutritional index in HPV-negative head and neck squamous cell carcinoma treated with upfront surgery: a multi-institutional series.","authors":"Michele Tomasoni,&nbsp;Cesare Piazza,&nbsp;Alberto Deganello,&nbsp;Paolo Bossi,&nbsp;Giancarlo Tirelli,&nbsp;Piero Nicolai,&nbsp;Maria Cristina Da Mosto,&nbsp;Gabriele Molteni,&nbsp;Vittorio Giacomarra,&nbsp;Pietro Canzi,&nbsp;Stefano Pelucchi,&nbsp;Jerry Polesel,&nbsp;Daniele Borsetto,&nbsp;Paolo Boscolo-Rizzo","doi":"10.14639/0392-100X-N2358","DOIUrl":"https://doi.org/10.14639/0392-100X-N2358","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the prognostic value of pre-treatment prognostic-nutritional index (PNI) in patients with HPV-negative head and neck squamous cell carcinoma (HNSCC).</p><p><strong>Methods: </strong>A multi-institutional retrospective series of HPV-negative, Stages II-IVB, HNSCCs treated with upfront surgery was evaluated. Correlation of pre-operative blood markers and PNI with 5-year overall (OS) and relapse-free (RFS) survival was tested using linear and restricted cubic spline models, as appropriate. The independent prognostic effect of patient-related features was assessed with multivariable models.</p><p><strong>Results: </strong>The analysis was conducted on 542 patients. PNI ≥ 49.6 (HR = 0.52; 95% CI, 0.37-0.74) and Neutrophil-to-Lymphocyte Ratio (NLR) > 4.2 (HR = 1.58; 95% CI, 1.06-2.35) confirmed to be independent prognosticators of OS, whereas only PNI ≥ 49.6 (HR = 0.44; 95% CI, 0.29-0.66) was independently associated with RFS. Among pre-operative blood parameters, only higher values of albuninaemia and lymphocyte count (> 1.08 x 10<sup>3</sup>/microL), and undetectable basophile count (= 0 10<sup>3</sup>/microL) were independently associated with better OS and RFS.</p><p><strong>Conclusions: </strong>PNI represents a reliable prognostic tool providing an independent measure of pre-operative immuno-metabolic performance. Its validity is supported by the independent prognostic role of albuminaemia and lymphocyte count, from which it is derived.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 3","pages":"170-182"},"PeriodicalIF":2.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ee/43/aoi-2023-03-170.PMC10198367.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9915806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients. TSH水平是甲状腺功能正常患者甲状腺结节恶性肿瘤的危险因素。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-06-01 DOI: 10.14639/0392-100X-N2288
Abdulaziz K Alaraifi, Mohammed Alessa, Leen O Hijazi, Areej M Alayed, Abdulaziz A Alsalem

Objective: With the increased prevalence of incidental thyroid cancer, determining the predictors of thyroid malignancy has become a source of debate. This study aimed to determine the impact of thyroid stimulating hormone (TSH) levels on rates of thyroid cancer in euthyroid patients.

Methods: A retrospective study included 421 patients who underwent thyroidectomy at a tertiary hospital between 2016 and 2020. Patients' demographics, history of cancer, pre-operative workup and final histology reports were obtained. The study sample was divided into two groups based on the final histopathology (benign vs malignant). The two groups were compared using the appropriate statistical tests to determine the predictors of thyroid cancer in euthyroid patients.

Results: TSH levels were significantly higher in patients with malignant nodules compared to those with benign nodules (1.94 vs 1.62, p = 0.002). It was 1.54 times more likely for thyroid nodules to be malignant when TSH levels were higher (p = 0.038). Meanwhile, larger nodules (> 4 cm) were significantly more prevalent in benign nodules (43.1%) than in malignant nodules (21.1%). Larger nodules decreased the possibility of thyroid cancer by 24% (OR = 0.760, p-value = 0.004).

Conclusions: High TSH levels in euthyroid patients were significantly correlated with the risk of thyroid malignancy. In addition, as Bethesda category proceeded toward malignancy, TSH levels increased. High TSH levels and small nodule diameters can be used as additional parameters in predicting thyroid cancer in euthyroid patients.

目的:随着偶发甲状腺癌患病率的增加,确定甲状腺恶性肿瘤的预测因素已成为争论的来源。本研究旨在确定促甲状腺激素(TSH)水平对甲状腺功能正常患者甲状腺癌发病率的影响。方法:回顾性研究纳入2016年至2020年在某三级医院行甲状腺切除术的421例患者。获得患者的人口统计学、癌症史、术前检查和最终组织学报告。研究样本根据最终的组织病理学(良性和恶性)分为两组。使用适当的统计检验对两组进行比较,以确定甲状腺功能正常患者甲状腺癌的预测因素。结果:恶性结节患者TSH水平明显高于良性结节患者(1.94 vs 1.62, p = 0.002)。当TSH水平较高时,甲状腺结节恶性的可能性增加1.54倍(p = 0.038)。同时,较大结节(> 4cm)在良性结节中的发生率(43.1%)明显高于恶性结节(21.1%)。较大结节使甲状腺癌的可能性降低24% (OR = 0.760, p值= 0.004)。结论:甲状腺功能正常患者高TSH水平与甲状腺恶性肿瘤发生风险显著相关。此外,随着Bethesda类别向恶性发展,TSH水平升高。高TSH水平和小结节直径可作为预测甲状腺功能正常患者甲状腺癌的附加参数。
{"title":"TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients.","authors":"Abdulaziz K Alaraifi,&nbsp;Mohammed Alessa,&nbsp;Leen O Hijazi,&nbsp;Areej M Alayed,&nbsp;Abdulaziz A Alsalem","doi":"10.14639/0392-100X-N2288","DOIUrl":"https://doi.org/10.14639/0392-100X-N2288","url":null,"abstract":"<p><strong>Objective: </strong>With the increased prevalence of incidental thyroid cancer, determining the predictors of thyroid malignancy has become a source of debate. This study aimed to determine the impact of thyroid stimulating hormone (TSH) levels on rates of thyroid cancer in euthyroid patients.</p><p><strong>Methods: </strong>A retrospective study included 421 patients who underwent thyroidectomy at a tertiary hospital between 2016 and 2020. Patients' demographics, history of cancer, pre-operative workup and final histology reports were obtained. The study sample was divided into two groups based on the final histopathology (benign <i>vs</i> malignant). The two groups were compared using the appropriate statistical tests to determine the predictors of thyroid cancer in euthyroid patients.</p><p><strong>Results: </strong>TSH levels were significantly higher in patients with malignant nodules compared to those with benign nodules (1.94 <i>vs</i> 1.62, p = 0.002). It was 1.54 times more likely for thyroid nodules to be malignant when TSH levels were higher (p = 0.038). Meanwhile, larger nodules (> 4 cm) were significantly more prevalent in benign nodules (43.1%) than in malignant nodules (21.1%). Larger nodules decreased the possibility of thyroid cancer by 24% (OR = 0.760, p-value = 0.004).</p><p><strong>Conclusions: </strong>High TSH levels in euthyroid patients were significantly correlated with the risk of thyroid malignancy. In addition, as Bethesda category proceeded toward malignancy, TSH levels increased. High TSH levels and small nodule diameters can be used as additional parameters in predicting thyroid cancer in euthyroid patients.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 3","pages":"183-188"},"PeriodicalIF":2.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/50/aoi-2023-03-183.PMC10198371.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9915805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatial analysis of transnasal olfactory cleft access: a computed tomography study. 经鼻嗅裂通道的空间分析:计算机断层扫描研究。
IF 2.1 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-06-01 DOI: 10.14639/0392-100X-N2118
Teffran Joey Chan, Melissa Lee, Andrew Vernu Thamboo

Objective: To our knowledge, the spatial access of naris to olfactory cleft has not been quantified. We aimed to study the relationship and space of middle turbinate, septum, anterior nasal spine and cribriform plate to improve topical medication delivery and drug applicators.

Methods: One hundred CT scans of patients (50 males, 50 females) over the age of 18 were included. Subjects with radiographic sinonasal pathology, previous surgery, or specific variant nasal anatomy were excluded. Scans were independently reviewed and bilateral measurements on bony landmarks were taken by two blinded authors. Inter-rater reliability was analysed with intraclass correlation.

Results: The average age was 46.26 years (σ = 14.0). Average distance from the anterior nasal spine to olfactory cleft was 52.3 mm (σ = 4.2 mm), and the average length of cribriform plate was 18.8 mm (σ = 3.8) with an angle relative to hard palate averaging -8.8 degrees below parallel (σ = 5.5 degree). The widths of the olfactory cleft at anterior and posterior edges of cribriform plate were 2.3 mm (σ = 0.7 mm) and 2.0 mm (σ = 0.7 mm).

Conclusions: The findings suggest a 52.3 mm distance from the naris to the anterior border of cribriform plate. The average width along this path was 3.2 mm, suggesting devices narrower than this could potentiate direct drug delivery access.

目的:据我们所知,鼻中隔通往嗅裂的空间尚未量化。我们旨在研究中鼻甲、鼻中隔、鼻前棘和楔形板的关系和空间,以改进局部给药和敷药器:方法:纳入 100 例 18 岁以上患者的 CT 扫描(男 50 例,女 50 例)。排除了患有放射学鼻窦病变、曾接受过手术或有特殊鼻腔解剖变异的受试者。扫描结果由两名双盲作者独立审核,并对双侧骨性标志物进行测量。评分者之间的可靠性通过类内相关性进行分析:平均年龄为 46.26 岁(σ = 14.0)。鼻前脊柱到嗅裂的平均距离为 52.3 毫米(σ = 4.2 毫米),楔形板的平均长度为 18.8 毫米(σ = 3.8),与硬腭的相对角度平均低于平行线 -8.8 度(σ = 5.5 度)。楔形板前后边缘的嗅裂宽度分别为 2.3 毫米(σ = 0.7 毫米)和 2.0 毫米(σ = 0.7 毫米):研究结果表明,从鼻骨到楔形板前缘的距离为 52.3 毫米。这条路径上的平均宽度为 3.2 毫米,这表明比这更窄的装置可以加强直接给药通道。
{"title":"Spatial analysis of transnasal olfactory cleft access: a computed tomography study.","authors":"Teffran Joey Chan, Melissa Lee, Andrew Vernu Thamboo","doi":"10.14639/0392-100X-N2118","DOIUrl":"10.14639/0392-100X-N2118","url":null,"abstract":"<p><strong>Objective: </strong>To our knowledge, the spatial access of naris to olfactory cleft has not been quantified. We aimed to study the relationship and space of middle turbinate, septum, anterior nasal spine and cribriform plate to improve topical medication delivery and drug applicators.</p><p><strong>Methods: </strong>One hundred CT scans of patients (50 males, 50 females) over the age of 18 were included. Subjects with radiographic sinonasal pathology, previous surgery, or specific variant nasal anatomy were excluded. Scans were independently reviewed and bilateral measurements on bony landmarks were taken by two blinded authors. Inter-rater reliability was analysed with intraclass correlation.</p><p><strong>Results: </strong>The average age was 46.26 years (σ = 14.0). Average distance from the anterior nasal spine to olfactory cleft was 52.3 mm (σ = 4.2 mm), and the average length of cribriform plate was 18.8 mm (σ = 3.8) with an angle relative to hard palate averaging -8.8 degrees below parallel (σ = 5.5 degree). The widths of the olfactory cleft at anterior and posterior edges of cribriform plate were 2.3 mm (σ = 0.7 mm) and 2.0 mm (σ = 0.7 mm).</p><p><strong>Conclusions: </strong>The findings suggest a 52.3 mm distance from the naris to the anterior border of cribriform plate. The average width along this path was 3.2 mm, suggesting devices narrower than this could potentiate direct drug delivery access.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 3","pages":"197-202"},"PeriodicalIF":2.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/08/33/aoi-2023-03-197.PMC10198370.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9613643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-neoplastic recurrences in otorhinolaryngological diseases Introduction. 耳鼻喉科疾病的非肿瘤性复发
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-04-01
Marco Benazzo
{"title":"Non-neoplastic recurrences in otorhinolaryngological diseases Introduction.","authors":"Marco Benazzo","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 Suppl 1","pages":"S1-S2"},"PeriodicalIF":2.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/13/aoi-2023-02-S1.PMC10159637.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10596341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of recurrent cerebrospinal fluid leak, current practices and open challenges. A systematic literature review. 复发性脑脊液漏的管理,当前做法和公开挑战。系统的文献综述。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-04-01 DOI: 10.14639/0392-100X-suppl.1-43-2023-02
Paolo Castelnuovo, Marco Valentini, Giorgio Sileo, Paolo Battaglia, Maurizio Bignami, Mario Turri-Zanoni
SUMMARY Cerebrospinal fluid leak (CSFL) is a rare pathological condition which requires prompt and adequate management due to the high rate of associated major complications. At present, CSFL can be successfully treated through endoscopic endonasal approaches with success rates higher than 90%. Despite this, CSFL recurrence may occur, and its management is critical and still represents a matter of debate. A systematic review of the literature on the management of recurrent CSFL was conducted. It included a cohort of 1,083 cases of CSFL treated with surgical or conservative approaches; 112 cases of recurrence were reported for an overall recurrence rate of 10.3%. Most of the leaks were localised in the anterior skull base (68.3%) and identification of recurrent CSFL may be troublesome. Therefore, the entire skull base must be meticulously examined and long-term follow-up is mandatory. The risk for CSFL recurrence is higher in patients affected by idiopathic intracranial hypertension (IIH), but its role in CSFL recurrence is yet to be understood. Recurrent CSFL must be repaired as soon as possible in order to reduce the risk of intracranial complications. The use of early post-operative CSF diversion by lumbar drain (LD) is currently a matter of debate even in case of CSFL recurrences.
{"title":"Management of recurrent cerebrospinal fluid leak, current practices and open challenges. A systematic literature review.","authors":"Paolo Castelnuovo,&nbsp;Marco Valentini,&nbsp;Giorgio Sileo,&nbsp;Paolo Battaglia,&nbsp;Maurizio Bignami,&nbsp;Mario Turri-Zanoni","doi":"10.14639/0392-100X-suppl.1-43-2023-02","DOIUrl":"https://doi.org/10.14639/0392-100X-suppl.1-43-2023-02","url":null,"abstract":"SUMMARY Cerebrospinal fluid leak (CSFL) is a rare pathological condition which requires prompt and adequate management due to the high rate of associated major complications. At present, CSFL can be successfully treated through endoscopic endonasal approaches with success rates higher than 90%. Despite this, CSFL recurrence may occur, and its management is critical and still represents a matter of debate. A systematic review of the literature on the management of recurrent CSFL was conducted. It included a cohort of 1,083 cases of CSFL treated with surgical or conservative approaches; 112 cases of recurrence were reported for an overall recurrence rate of 10.3%. Most of the leaks were localised in the anterior skull base (68.3%) and identification of recurrent CSFL may be troublesome. Therefore, the entire skull base must be meticulously examined and long-term follow-up is mandatory. The risk for CSFL recurrence is higher in patients affected by idiopathic intracranial hypertension (IIH), but its role in CSFL recurrence is yet to be understood. Recurrent CSFL must be repaired as soon as possible in order to reduce the risk of intracranial complications. The use of early post-operative CSF diversion by lumbar drain (LD) is currently a matter of debate even in case of CSFL recurrences.","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 Suppl 1","pages":"S14-S27"},"PeriodicalIF":2.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/40/fd/aoi-2023-02-S14.PMC10159643.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10284627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of sleep disordered breathing relapse after surgery. 手术后睡眠呼吸障碍复发的治疗。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-04-01 DOI: 10.14639/0392-100X-suppl.1-43-2023-13
Claudio Vicini, Giovanni Cammaroto
SUMMARY This narrative review provides a general overview of the management of relapses after surgery for the treatment of sleep disordered breathing. This clinical scenario represents a challenging field, but fortunately several therapeutic options are included in sleep surgeons’ armamentarium. Each therapeutic modality is described in detail in a dedicated section.
{"title":"Treatment of sleep disordered breathing relapse after surgery.","authors":"Claudio Vicini,&nbsp;Giovanni Cammaroto","doi":"10.14639/0392-100X-suppl.1-43-2023-13","DOIUrl":"https://doi.org/10.14639/0392-100X-suppl.1-43-2023-13","url":null,"abstract":"SUMMARY This narrative review provides a general overview of the management of relapses after surgery for the treatment of sleep disordered breathing. This clinical scenario represents a challenging field, but fortunately several therapeutic options are included in sleep surgeons’ armamentarium. Each therapeutic modality is described in detail in a dedicated section.","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 Suppl 1","pages":"S103-S110"},"PeriodicalIF":2.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/10/aoi-2023-02-S103.PMC10159645.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10578728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review. 生物时代如何处理 CRSwNP 患者术后复发:综述。
IF 2.1 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-04-01 DOI: 10.14639/0392-100X-suppl.1-43-2023-01
Eugenio De Corso, Stefano Settimi, Claudio Montuori, Alessandro Cantiani, Marco Corbò, Giuseppe Alberto Di Bella, Fabio Sovardi, Fabio Pagella, Mario Rigante, Giulio Cesare Passali, Gaetano Paludetti, Jacopo Galli

Objective: This narrative review analyses factors affecting recurrence of Chronic rhinosinusitis with nasal polyps (CRSwNP) after surgery, such as type, extension and completeness of endoscopic sinus surgery (ESS). We also described new implications in the management of recurrences after the advent of biologics.

Methods: We identified four topics: definition of disease state; factors linked to recurrence of polyps; evaluation and management of recurrence in clinical practice.

Results: We analysed the differences between exacerbation and recurrence, as well as the concept of "controlled disease". We focused on potential predictors of recurrence after ESS, such as type 2 inflammation, asthma, aspirin-exacerbated respiratory disease, incomplete initial surgery and lack of adherence to long-term post-operative local corticosteroids. We discussed the new aspects of diagnosis and treatment of recurrences after surgery, summarising our suggestions in a detailed algorithm for practical management of patients with recurrent disease.

Conclusions: The results emphasised the importance of accurate evaluation of patients with CRSwNP recurrence, focusing on the reasons of failure and risk of disease progression, in order to guide personalised interventions. It is crucial to define the concept of appropriate surgery, which affects the choice between starting a biologic or repeating surgery.

目的:这篇叙述性综述分析了影响慢性鼻窦炎伴鼻息肉(CRSwNP)术后复发的因素,如内窥镜鼻窦手术(ESS)的类型、范围和完整性。我们还介绍了生物制剂问世后对复发治疗的新影响:我们确定了四个主题:疾病状态的定义;息肉复发的相关因素;临床实践中对复发的评估和管理:我们分析了病情加重与复发之间的区别,以及 "病情得到控制 "的概念。我们重点研究了ESS术后复发的潜在预测因素,如2型炎症、哮喘、阿司匹林加重的呼吸系统疾病、初次手术不彻底以及术后未长期使用局部皮质类固醇激素。我们讨论了术后复发诊断和治疗的新方面,并总结了我们的建议,为复发患者的实际管理提供了详细的算法:研究结果强调了对 CRSwNP 复发患者进行准确评估的重要性,重点关注失败的原因和疾病进展的风险,以指导个性化干预。界定适当手术的概念至关重要,这将影响到开始使用生物制剂还是重复手术的选择。
{"title":"How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review.","authors":"Eugenio De Corso, Stefano Settimi, Claudio Montuori, Alessandro Cantiani, Marco Corbò, Giuseppe Alberto Di Bella, Fabio Sovardi, Fabio Pagella, Mario Rigante, Giulio Cesare Passali, Gaetano Paludetti, Jacopo Galli","doi":"10.14639/0392-100X-suppl.1-43-2023-01","DOIUrl":"10.14639/0392-100X-suppl.1-43-2023-01","url":null,"abstract":"<p><strong>Objective: </strong>This narrative review analyses factors affecting recurrence of Chronic rhinosinusitis with nasal polyps (CRSwNP) after surgery, such as type, extension and completeness of endoscopic sinus surgery (ESS). We also described new implications in the management of recurrences after the advent of biologics.</p><p><strong>Methods: </strong>We identified four topics: definition of disease state; factors linked to recurrence of polyps; evaluation and management of recurrence in clinical practice.</p><p><strong>Results: </strong>We analysed the differences between exacerbation and recurrence, as well as the concept of \"controlled disease\". We focused on potential predictors of recurrence after ESS, such as type 2 inflammation, asthma, aspirin-exacerbated respiratory disease, incomplete initial surgery and lack of adherence to long-term post-operative local corticosteroids. We discussed the new aspects of diagnosis and treatment of recurrences after surgery, summarising our suggestions in a detailed algorithm for practical management of patients with recurrent disease.</p><p><strong>Conclusions: </strong>The results emphasised the importance of accurate evaluation of patients with CRSwNP recurrence, focusing on the reasons of failure and risk of disease progression, in order to guide personalised interventions. It is crucial to define the concept of appropriate surgery, which affects the choice between starting a biologic or repeating surgery.</p>","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 Suppl. 1","pages":"S3-S13"},"PeriodicalIF":2.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ba/b4/aoi-2023-02-S3.PMC10159635.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10284631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrence of conductive hearing loss after stapes surgery: a narrative review. 镫骨手术后传导性听力损失复发的研究综述。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-04-01 DOI: 10.14639/0392-100X-suppl.1-43-2023-07
Ignacio Javier Fernandez, Federico Rondini, Livio Presutti, Giulia Molinari
SUMMARY Among the functional failures of stapes surgery is recurrent conductive hearing loss, which can occur after a variable period of hearing improvement, from days/months up to many years after surgery. The most common cause of recurrent conductive hearing loss is prosthesis displacement, while fibrous adhesions or stapedotomy hole/oval window re-obliteration due to otosclerosis, occur less frequently. High resolution computed tomography plays an important role in the identification of the cause of hearing loss recurrence. Parallel to this, intra-operative exploration of the middle ear is crucial to confirm the cause of failure and address its treatment, possibly restoring hearing. While generally worse than after primary surgery, hearing outcomes after revision stapes surgery have improved thanks to advancements in pre-operative assessment, intra-operative view and technical refinements.
{"title":"Recurrence of conductive hearing loss after stapes surgery: a narrative review.","authors":"Ignacio Javier Fernandez,&nbsp;Federico Rondini,&nbsp;Livio Presutti,&nbsp;Giulia Molinari","doi":"10.14639/0392-100X-suppl.1-43-2023-07","DOIUrl":"https://doi.org/10.14639/0392-100X-suppl.1-43-2023-07","url":null,"abstract":"SUMMARY Among the functional failures of stapes surgery is recurrent conductive hearing loss, which can occur after a variable period of hearing improvement, from days/months up to many years after surgery. The most common cause of recurrent conductive hearing loss is prosthesis displacement, while fibrous adhesions or stapedotomy hole/oval window re-obliteration due to otosclerosis, occur less frequently. High resolution computed tomography plays an important role in the identification of the cause of hearing loss recurrence. Parallel to this, intra-operative exploration of the middle ear is crucial to confirm the cause of failure and address its treatment, possibly restoring hearing. While generally worse than after primary surgery, hearing outcomes after revision stapes surgery have improved thanks to advancements in pre-operative assessment, intra-operative view and technical refinements.","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 Suppl 1","pages":"S56-S60"},"PeriodicalIF":2.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ff/ca/aoi-2023-02-S56.PMC10159633.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10578723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study. 复发性喉乳头状瘤病:多模式治疗策略。文献回顾及多中心回顾性研究。
IF 2 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2023-04-01 DOI: 10.14639/0392-100X-suppl.1-43-2023-14
Giulia Bertino, Fabio Pedretti, Simone Mauramati, Marta Filauro, Alberto Vallin, Francesco Mora, Erika Crosetti, Giovanni Succo, Giorgio Peretti, Marco Benazzo
<p><strong>Objectives: </strong>Recurrent respiratory papillomatosis (RRP) is a benign, rare disease caused by Human Papilloma Virus (HPV) that can be divided into juvenile and adult forms. The course of the disease is variable, but is usually more aggressive in the juvenile form. The standard surgical treatment is represented by CO<sub>2</sub> laser resection, although photoangiolytic lasers represent a valid alternative. Adjuvant therapies have been proposed for disease control in case of frequent surgical resections or spreading into the lower airways. In recent years, the development of immunotherapy led to the use of bevacizumab either intratumorally or intravenously, but the most promising therapeutic development is represented by HPV vaccination. This paper aims to present a narrative review of the literature and the experience of three different University Centres in the treatment of RRP.</p><p><strong>Methods: </strong>A retrospective analysis of the clinical charts of all patients affected by laryngeal papillomatosis and treated in three different University Centres between 2002 and 2022 was performed. The following parameters were collected: sex, age at first evaluation, sites of larynx involved, HPV type, type of first surgical treatment, presence and number of recurrences, surgical treatment of recurrences, adjuvant therapies, side effects and status at last follow-up.</p><p><strong>Results: </strong>Seventy-eight patients were available for evaluation. Of these, 88% had adult onset RRP (Ao-RRP) and 12% juvenile onset RRP (Jo-RRP). The glottis was the most frequently involved subsite; all patients were submitted to surgical resection with CO<sub>2</sub> laser under general anaesthesia. Recurrences appeared in 79% of the patients, the patients who did not recur were all adults. The mean number of recurrences was 9 (range 1-110). Recurrences were more frequent in children (M = 20; range 2-110) than adults (M = 5; range 1-21). Thirty-two (52%) of the 62 patients who recurred were re-treated with CO<sub>2</sub> laser under general anaesthesia, while office-based treatment with a photoangiolytic laser was preferred in the remaining 30 (48%) patients. Adjuvant treatments were applied in 26 patients. The analysis of the course of the disease showed that in the 9 patients with Jo-RRP, 6 (67%) were free of lesions at the last follow-up, while the other 3 (33%) had papillomas. Of the 69 patients with Ao-RRP, 53 (77%) were alive and free of disease at the last visit, 14 (21%) were alive with disease, 1 (1%) was lost at follow-up and 1 (1%) died for other disease. Severe side effects were not observed except for 2 patients, who developed posterior glottic stenosis.</p><p><strong>Conclusions: </strong>Our results confirmed the literature review. RRP is a potentially aggressive disease, especially in juvenile onset. Surgical resection is still first-line treatment, but in case of multiple recurrences the use of adjuvant therapies must be taken int
目的:复发性呼吸道乳头状瘤病(RRP)是由人乳头状瘤病毒(HPV)引起的一种罕见的良性疾病,可分为少年型和成年型。这种疾病的病程是多变的,但通常在幼年时更具侵袭性。标准的手术治疗是CO2激光切除,尽管光血管溶解激光是一种有效的替代方法。在频繁手术切除或扩散到下呼吸道的情况下,已经提出了辅助治疗来控制疾病。近年来,免疫疗法的发展导致贝伐单抗在肿瘤内或静脉注射的使用,但最有希望的治疗发展是HPV疫苗接种。本文旨在提出的文献和三个不同的大学中心在治疗RRP的经验的叙述回顾。方法:回顾性分析2002年至2022年间在三所不同的大学中心治疗的喉乳头状瘤病患者的临床资料。收集以下参数:性别、初次评估时的年龄、喉部受累部位、HPV类型、首次手术治疗类型、复发的存在和次数、复发的手术治疗、辅助治疗、副作用和最后随访时的情况。结果:78例患者可用于评估。其中88%为成人起病RRP (Ao-RRP), 12%为青少年起病RRP (Jo-RRP)。声门是最常受累的部位;所有患者均在全身麻醉下行CO2激光手术切除。79%的患者出现复发,未复发的患者均为成人。平均复发次数为9次(范围1-110次)。儿童复发率较高(M = 20;范围2-110)比成人(M = 5;范围21)。62例复发患者中有32例(52%)在全身麻醉下再次接受CO2激光治疗,而其余30例(48%)患者首选以办公室为基础的光溶血管激光治疗。辅助治疗26例。病程分析显示,9例Jo-RRP患者中,6例(67%)末次随访无病变,3例(33%)有乳头状瘤。在69例Ao-RRP患者中,53例(77%)在最后一次访问时存活且无疾病,14例(21%)存活且有疾病,1例(1%)在随访中丢失,1例(1%)因其他疾病死亡。除2例患者出现后声门狭窄外,未见严重副作用。结论:我们的结果证实了文献综述。RRP是一种潜在的侵袭性疾病,尤其是在青少年发病时。手术切除仍是一线治疗方法,但在多次复发的情况下,必须考虑辅助治疗的使用。
{"title":"Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.","authors":"Giulia Bertino,&nbsp;Fabio Pedretti,&nbsp;Simone Mauramati,&nbsp;Marta Filauro,&nbsp;Alberto Vallin,&nbsp;Francesco Mora,&nbsp;Erika Crosetti,&nbsp;Giovanni Succo,&nbsp;Giorgio Peretti,&nbsp;Marco Benazzo","doi":"10.14639/0392-100X-suppl.1-43-2023-14","DOIUrl":"https://doi.org/10.14639/0392-100X-suppl.1-43-2023-14","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;Recurrent respiratory papillomatosis (RRP) is a benign, rare disease caused by Human Papilloma Virus (HPV) that can be divided into juvenile and adult forms. The course of the disease is variable, but is usually more aggressive in the juvenile form. The standard surgical treatment is represented by CO&lt;sub&gt;2&lt;/sub&gt; laser resection, although photoangiolytic lasers represent a valid alternative. Adjuvant therapies have been proposed for disease control in case of frequent surgical resections or spreading into the lower airways. In recent years, the development of immunotherapy led to the use of bevacizumab either intratumorally or intravenously, but the most promising therapeutic development is represented by HPV vaccination. This paper aims to present a narrative review of the literature and the experience of three different University Centres in the treatment of RRP.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective analysis of the clinical charts of all patients affected by laryngeal papillomatosis and treated in three different University Centres between 2002 and 2022 was performed. The following parameters were collected: sex, age at first evaluation, sites of larynx involved, HPV type, type of first surgical treatment, presence and number of recurrences, surgical treatment of recurrences, adjuvant therapies, side effects and status at last follow-up.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Seventy-eight patients were available for evaluation. Of these, 88% had adult onset RRP (Ao-RRP) and 12% juvenile onset RRP (Jo-RRP). The glottis was the most frequently involved subsite; all patients were submitted to surgical resection with CO&lt;sub&gt;2&lt;/sub&gt; laser under general anaesthesia. Recurrences appeared in 79% of the patients, the patients who did not recur were all adults. The mean number of recurrences was 9 (range 1-110). Recurrences were more frequent in children (M = 20; range 2-110) than adults (M = 5; range 1-21). Thirty-two (52%) of the 62 patients who recurred were re-treated with CO&lt;sub&gt;2&lt;/sub&gt; laser under general anaesthesia, while office-based treatment with a photoangiolytic laser was preferred in the remaining 30 (48%) patients. Adjuvant treatments were applied in 26 patients. The analysis of the course of the disease showed that in the 9 patients with Jo-RRP, 6 (67%) were free of lesions at the last follow-up, while the other 3 (33%) had papillomas. Of the 69 patients with Ao-RRP, 53 (77%) were alive and free of disease at the last visit, 14 (21%) were alive with disease, 1 (1%) was lost at follow-up and 1 (1%) died for other disease. Severe side effects were not observed except for 2 patients, who developed posterior glottic stenosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Our results confirmed the literature review. RRP is a potentially aggressive disease, especially in juvenile onset. Surgical resection is still first-line treatment, but in case of multiple recurrences the use of adjuvant therapies must be taken int","PeriodicalId":6890,"journal":{"name":"Acta Otorhinolaryngologica Italica","volume":"43 Suppl. 1","pages":"S111-S122"},"PeriodicalIF":2.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/68/aoi-2023-02-S111.PMC10159644.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10284634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Acta Otorhinolaryngologica Italica
全部 Energy Environ. Asia-Pac. J. Atmos. Sci. Org. Geochem. essentia law Merchant Shipping Act 1995 Environ. Eng. Manage. J. Environ. Mol. Mutagen. J. Earth Sci. ATMOSPHERE-BASEL Geol. Ore Deposits Environmental dermatology : the official journal of the Japanese Society for Contact Dermatitis Exp. Mol. Pathol. Clean Technol. Environ. Policy J. Earth Syst. Sci. TECTONICS Enzyme Research Acta Geophys. Exp. Eye Res. SPACE WEATHER Energy Storage IZV-PHYS SOLID EART+ Ore Geol. Rev. Theor. Appl. Climatol. EUR UROL GEOL BELG Engineering Science and Technology, an International Journal Geochem. Perspect. Geol. J. Exp. Anim. J. Sea Res. Espacio Tiempo y Forma. Serie VI, Geografía SOLA P GEOLOGIST ASSOC Int. J. Biometeorol. ACTA GEOTECH SLOV J. Paleontol. Polar Sci. PERIOD MINERAL Acta Geophys. ERN: Other Microeconomics: General Equilibrium & Disequilibrium Models of Financial Markets (Topic) PROD OPER MANAG Geochem. Int. PROD PLAN CONTROL Engineering Structures and Technologies Indonesia Law Review Newsl. Stratigr. Indian Journal of Clinical and Experimental Ophthalmology PALAEOGEOGR PALAEOCL Energy Ecol Environ ECOSYSTEMS ECOL RESTOR Adv. Meteorol. TELLUS B TELLUS A Indonesian Journal of Pure and Applied Chemistry Infection Control & Hospital Epidemiology Chem. Ecol. Memai Heiko Igaku GEOSPHERE GEOPHYSICS J. Atmos. Chem. Environmental Claims Journal Int J Ion Mobil Spectrom Geophys. Prospect. Photogramm. Rec. Int. Geol. Rev. Yan Ke Xue Bao (Hong Kong) CURR OPIN SOLID ST M PETROLOGY+ Focus on Autism and Other Developmental Disabilities WEATHER CLIM SOC J Polit Econ Ecol. Monogr. Electrochem. Energy Rev. Archaeol. Anthropol. Sci. Rev. Geophys. Journal of the Economics of Ageing International Journal of Biomaterials Pet. Geosci. Equine veterinary journal. Supplement J. Exp. Nanosci. Swiss J. Palaeontol. Aquat. Geochem. ICHNOS Corros. Sci. EST J EARTH SCI Econ Rec J. Atmos. Oceanic Technol. Journal of Productivity Analysis Korean J. Met. Mater. Exp. Biol. Med. ERN: Regulation (IO) (Topic) Energy Environ. Mater. Oper. Res. Perspect. Economics of Education Review Asian Economic Journal RARE METAL MAT ENG GEOMAT NAT HAZ RISK TECTONOPHYSICS J. Adv. Model. Earth Syst. Swiss J. Geosci.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1